IOIS WEBINAR 05

Controversies in Tubercular Uveitis

OBJECTIVES
This webinar aims to explore major controversies in the diagnosis and management of tubercular uveitis through case-based debates and regional perspectives. It will compare phenotypic and laboratory criteria that guide initiation of anti-tubercular therapy in different endemic settings and examine the interpretation of interferon release assays in clinical decision making. By integrating experiences from multiple international societies, the session seeks to promote evidence informed, pragmatic, and context sensitive approaches to tubercular uveitis care worldwide.

PROGRAMME
Introduction to the webinar (2`)

Case 1: TBC (6`)
Case 2: TBC (6`)

Debate 1:
Phenotypes and laboratory tests that necessitate anti-TB therapy in India
TBC (IND; 10`)
Debate 2:
Phenotypes and laboratory tests that necessitate anti-TB therapy in Brazil
TBC (BRA; 10`)
Summary of the Debate: by Talin Barisani-Asenbauer (5`)

Debate 3:
Positive interferon release assay is almost always TB
TBC (IDN; 10`)
Debate 4:
Positive Interferon release assay is not always TB
TBC (MEX; 10`)
Summary of the Debate: by Harvey Uy (5`)

Our Sponsors

We gratefully acknowledge the sponsors of the IOIS Educational Programme for their valued support. Their contribution helps IOIS deliver high-quality education and advance learning worldwide.